Search research articles
Contact Us
Filters
Showing results (91-100 of 170) with videos related to
Page
of 17
Sort By:
Journal of Virology
|
October 19, 2023
Functional and transcriptional heterogeneity within the massively expanding HLADR<sup>+</sup>CD38<sup>+</sup> CD8 T cell population in acute febrile dengue patients
Prabhat Singh, Prashant Bajpai, Deepti Maheshwari, et al.
Cancer
|
October 21, 2018
Cisplatin versus cetuximab with definitive concurrent radiotherapy for head and neck squamous cell carcinoma: An analysis of Veterans Health Affairs data
Joshua M Bauml, Ravi Vinnakota, Yeun-Hee Anna Park, et al.
JCO Oncology Practice
|
May 27, 2020
Management of Lung Cancer During the COVID-19 Pandemic
Aditi P Singh, Abigail T Berman, Melina E Marmarelis, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 22, 2026
Osimertinib dose-reduction and survival in 1L EGFR-mutated metastatic non-small cell lung cancer (mNSCLC)
Adam Barsouk, Alec Heidlauf, Keshav Goel, et al.
Scientific Reports
|
May 12, 2021
Combining radiomic phenotypes of non-small cell lung cancer with liquid biopsy data may improve prediction of response to EGFR inhibitors
Bardia Yousefi, Michael J LaRiviere, Eric A Cohen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 22, 2022
COAST: An Open-Label, Phase II, Multidrug Platform Study of Durvalumab Alone or in Combination With Oleclumab or Monalizumab in Patients With Unresectable, Stage III Non-Small-Cell Lung Cancer
Roy S Herbst, Margarita Majem, Fabrice Barlesi, et al.
The British Journal of Radiology
|
October 11, 2019
Risk of post-operative, pre-radiotherapy contralateral neck recurrence in patients treated with surgery followed by adjuvant radiotherapy for human papilloma virus-associated tonsil cancer
Jared Gershowitz, Hann-Hsiang Chao, Abigail Doucette, et al.
The Oncologist
|
May 15, 2023
A Phase II Open-Label Trial of Binimetinib and Hydroxychloroquine in Patients With Advanced KRAS-Mutant Non-Small Cell Lung Cancer
Charu Aggarwal, Alisha P Maity, Joshua M Bauml, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 13, 2024
Real-world outcomes of atypical EGFR-mutated metastatic non-small cell lung cancer (mNSCLC)treated with osimertinib (osi) vs. Afatinib or erlotinib
Adam Barsouk, Omar Elghawy, Alec Heidlauf, et al.
International Journal of Particle Therapy
|
November 28, 2019
Quality of Life of Postoperative Photon versus Proton Radiation Therapy for Oropharynx Cancer
Sonam Sharma, Olivia Zhou, Reid Thompson, et al.
Page
of 17
Search research articles
Search
Showing results (91-100 of 170) with videos related to
Sort By:
Page
of 17
Journal of Virology
|
October 19, 2023
Functional and transcriptional heterogeneity within the massively expanding HLADR<sup>+</sup>CD38<sup>+</sup> CD8 T cell population in acute febrile dengue patients
Prabhat Singh, Prashant Bajpai, Deepti Maheshwari, et al.
Cancer
|
October 21, 2018
Cisplatin versus cetuximab with definitive concurrent radiotherapy for head and neck squamous cell carcinoma: An analysis of Veterans Health Affairs data
Joshua M Bauml, Ravi Vinnakota, Yeun-Hee Anna Park, et al.
JCO Oncology Practice
|
May 27, 2020
Management of Lung Cancer During the COVID-19 Pandemic
Aditi P Singh, Abigail T Berman, Melina E Marmarelis, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 22, 2026
Osimertinib dose-reduction and survival in 1L EGFR-mutated metastatic non-small cell lung cancer (mNSCLC)
Adam Barsouk, Alec Heidlauf, Keshav Goel, et al.
Scientific Reports
|
May 12, 2021
Combining radiomic phenotypes of non-small cell lung cancer with liquid biopsy data may improve prediction of response to EGFR inhibitors
Bardia Yousefi, Michael J LaRiviere, Eric A Cohen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 22, 2022
COAST: An Open-Label, Phase II, Multidrug Platform Study of Durvalumab Alone or in Combination With Oleclumab or Monalizumab in Patients With Unresectable, Stage III Non-Small-Cell Lung Cancer
Roy S Herbst, Margarita Majem, Fabrice Barlesi, et al.
The British Journal of Radiology
|
October 11, 2019
Risk of post-operative, pre-radiotherapy contralateral neck recurrence in patients treated with surgery followed by adjuvant radiotherapy for human papilloma virus-associated tonsil cancer
Jared Gershowitz, Hann-Hsiang Chao, Abigail Doucette, et al.
The Oncologist
|
May 15, 2023
A Phase II Open-Label Trial of Binimetinib and Hydroxychloroquine in Patients With Advanced KRAS-Mutant Non-Small Cell Lung Cancer
Charu Aggarwal, Alisha P Maity, Joshua M Bauml, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 13, 2024
Real-world outcomes of atypical EGFR-mutated metastatic non-small cell lung cancer (mNSCLC)treated with osimertinib (osi) vs. Afatinib or erlotinib
Adam Barsouk, Omar Elghawy, Alec Heidlauf, et al.
International Journal of Particle Therapy
|
November 28, 2019
Quality of Life of Postoperative Photon versus Proton Radiation Therapy for Oropharynx Cancer
Sonam Sharma, Olivia Zhou, Reid Thompson, et al.
Page
of 17